Login / Signup

Longitudinal Clinical and Biological Characteristics in Juvenile-Onset Huntington's Disease.

Jordan L SchultzDouglas R LangbehnHend M Al-KaylaniEllen van der PlasTimothy R KoscikEric A EppingPatricia B Espe-PfeiferErin P MartinDavid J MoserVincent A MagnottaPeggy C Nopoulos
Published in: Movement disorders : official journal of the Movement Disorder Society (2022)
These findings demonstrate that structural brain imaging and clinical measures in JOHD may be potential biomarkers of disease progression for use in clinical trials. Collaborative efforts are required to validate these results in a larger cohort of patients with JOHD. © 2022 International Parkinson and Movement Disorder Society.
Keyphrases
  • clinical trial
  • quality improvement
  • randomized controlled trial
  • mass spectrometry
  • multiple sclerosis
  • photodynamic therapy
  • brain injury
  • phase ii
  • open label
  • subarachnoid hemorrhage
  • fluorescence imaging
  • phase iii